Ann: International Market Milestone Achieved with UK Distribution, page-128

Agree, well done to the long term holders here.

I had another look at PCK a month ago and caught up with Daffas at Techknow, the stock was 3c and looked destined for another capital raise before a complete rabbit out of the hat.

The Australian Government license could well turn out to be around $12M a year if all the aged care facilities were to come on board at market rates. Then the UK with NHS. FDA is the last real regulatory hurdle.

Looks very well valued here considering the market cap after todays rise. Great to see Australian technology making a real difference.